Skip to main content
SpringerLink
Log in

Spondyloarthritiden

  • Chapter
Rheumatologie aus der Praxis

  • 1191 Accesses

Zusammenfassung

Die Begriffe Spondyloarthritis (SpA), Spondyloarthropathie oder Spondylarthropathie (heute wird bevorzugt der Terminus Spondyloarthritis verwendet) bezeichnen entzündlich rheumatische Erkrankungen, die einige typische klinische, serologische und genetische Gemeinsamkeiten aufweisen. Charakteristisch ist eine Beteiligung des Achsenskeletts, der Sehnenansätze im Sinne einer Enthesitis (z. B. ein Fersenschmerz) oder eine asymmetrische Oligoarthritis der unteren Extremitäten. Auch extraartikuläre Manifestationen wie eine Uveitis anterior sind häufig nachweisbar. Ihnen zugeordnet werden die ankylosierende Spondylitis (Morbus Bechterew), die Psoriasisarthritis, die reaktiven Arthritiden, die enteropathischen Arthritiden, die undifferenzierten Spondyloarthritiden, die keiner der angeführten Diagnosen zugeordnet werden können und das sehr seltene Synovitis-Akne-Pustulose-Hyperostose-Osteitis-Syndrom (SAPHO-Syndrom), dessen Einordnung aber uneinheitlich beurteilt wird (Tabelle 1).

Spondyloarthritiden

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Amor B, Silva Santos R, Nahal R, Dougados M (1994) Predictive factors for the long term outcome of Spondyloarthropathies. J Rheumatol 21: 1883–1887

    CAS  PubMed  Google Scholar 

  2. Baraliakos X, Listing J, Brandt J et al (2005) Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab. Arthritis Res Ther 7: R439–R444

    Article  CAS  PubMed  Google Scholar 

  3. Brandt J, Listing J, Haibel H et al (2005) Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis. Rheumatology 44: 342–348

    Article  CAS  PubMed  Google Scholar 

  4. Braun J, Bollow M, Remlinger G et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41: 58–67. Reply in: Arthritis & Rheumatism

    Article  CAS  PubMed  Google Scholar 

  5. Braun J, Brandt J, Listing J et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359: 1187–1193

    Article  CAS  PubMed  Google Scholar 

  6. Braun J, Davis J, Dougados M et al (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65: 316–320

    Article  CAS  PubMed  Google Scholar 

  7. Braun J, Landewe R, Hermann KG et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 54: 1646–1652

    Article  CAS  PubMed  Google Scholar 

  8. Braun J, Sieper J (2006) Spondyloarthritiden. Z Rheumatol 65: 613–632

    Article  CAS  PubMed  Google Scholar 

  9. Blum U, Buitrago-Tellez C, Mundinger A et al (1996) Magnetic resonance imaging (MRI) for detection of active sacroiliitis — a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. J Rheumatol 23: 2107–2115

    CAS  PubMed  Google Scholar 

  10. Brown MA, Wordsworth BP, Reveille JD (2006) Genetics of ankylosing spondylitis. Clin Exp Rheumatol 6 [Suppl 28] 20: S 43–49

    Google Scholar 

  11. Calin A, Garret S, Whitelock H et al (1994) A new approach to defining functional ability in ankolysing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21: 2281–2285

    CAS  PubMed  Google Scholar 

  12. Calin A, Porta J, Fries JF, Schurmann DJ (1977) Clinical history as a screening test für ankylosing spondylitis. JAMA 237(24): 2613–2614

    Article  CAS  PubMed  Google Scholar 

  13. Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapie interventions forankylosing spondylitis. Cochrane Database Syst Rev 1: CD002822 18254008

    Google Scholar 

  14. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34: 1218–1227

    Article  CAS  PubMed  Google Scholar 

  15. Ebner W (2008) Therapieoptionen bei Morbus Bechterew. J Miner Stoffwechs 15: 84–88

    Google Scholar 

  16. Ebner W (2008) Früherkennung des Morbus Bechterew in der allgemeinmedizinischen Praxis ÖGAM Newsletter 4

    Google Scholar 

  17. Falkenbach A (Hrsg) (2005) Morbus Bechterew, Beratung, Betreuung, Behandlung. Springer, Wien New York

    Google Scholar 

  18. Garret S, Jenkinson T, Kennedy LG, et al (1994) A new approach to defining disease status in ankolysing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21: 2286–2291

    Google Scholar 

  19. Haibel H, Rudwaleit M, Braun J, Sieper J (2002) Epidemiologie und Versorgung im Bereich der Spondyloarthropathien. Z Rheumatol 61: 30–38

    Article  CAS  PubMed  Google Scholar 

  20. Langer H-E (2008) Biologicals in der frühen Behandlung des M. Bechterew und verwandter Spondyloarthritiden. Wien Med Wochenschr 158: 200–205

    Article  PubMed  Google Scholar 

  21. Manger B (2005) Checkliste XXL Rheumatologie, 3. vollständig überarbeitete Auflage. Thieme, Stuttgart

    Google Scholar 

  22. Mau W, Zeidler H (2008). Spondylitis ankylosans. In: Zeidler H Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Auflage. Springer, Berlin Heidelberg New York, pp907–923

    Chapter  Google Scholar 

  23. Picozzi M, Weber M, Frey RA, Baumberger H (2002) Spondylitis ankylosans (M. Bechterew): Frühdiagnose und das bunte Bild der Krankheit. Schweiz Med Forum 2: 232–237

    Google Scholar 

  24. Rainer F, Rudwaleit M (2005) Diagnosestellung. In: Falkenbach A (Hrsg) Morbus Bechterew, Beratung, Betreuung, Behandlung. Springer, Wien New York, pp23–54

    Google Scholar 

  25. Rudwaleit M, Braun J, Sieper J (2009) ASAS-Klassifkationskriterien für axiale Spondyloarthritis. Z Rheumatol 68: 591–593

    Article  CAS  PubMed  Google Scholar 

  26. Rudwaleit M, Feldtkeller E, Sieper J (2006). Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis 65: 1251–1252

    Article  CAS  PubMed  Google Scholar 

  27. Rudwaleit M, Landewé R, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68: 770–776

    Article  CAS  PubMed  Google Scholar 

  28. Rudwaleit M, Listing J, Brandt J Braun J, Sieper J (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63: 665–70

    Article  CAS  PubMed  Google Scholar 

  29. Rudwaleit M, Metter A, Listing J et al (2006) Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54: 569–578

    Article  PubMed  Google Scholar 

  30. Rudwaleit M, Metter A, Listing J et al (2002) Clinical parameters in the differentiation of inflammatory back pain from non-inflammatory back pain. Ann Rheum Dis 61 [Suppl 1]: 57

    Article  Google Scholar 

  31. Rudwaleit M, Sieper J (2005) Frühdiagnose von Spondyloarthritiden mit besonderer Betonung auf die axialen Formen. Z Rheumatol 64: 524–530

    Article  CAS  PubMed  Google Scholar 

  32. Rudwaleit M, Sieper J (2005) Diagnose und Frühdiagnose der Spondylitis ankylosans (Morbus Bechterew). Morbus Bechterew J 26: 4–9

    Google Scholar 

  33. Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68: 777–783

    Article  CAS  PubMed  Google Scholar 

  34. Sieper J, Braun J, Rudwaleit M et al (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61 [Suppl 3]: iii8–18

    PubMed  Google Scholar 

  35. Sieper J, Rudwaleit M, Khan MA, Braun J (2006) Concepts and epidemiology of spondylarthritis. Best Pract Res Clin Rheumatol 20: 401–417

    Article  PubMed  Google Scholar 

  36. Sieper J, van der Heijde D, Landewé R et al (2009) New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 68: 784–788

    Article  CAS  PubMed  Google Scholar 

  37. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361–368

    Article  PubMed  Google Scholar 

  38. Van der Linden S, Falkenbach A (2005) Prognose. In. Falkenbach A (Hrsg) Morbus Bechterew, Beratung, Betreuung, Behandlung. Springer, Wien New York, pp71–81

    Google Scholar 

  39. Weber U, Kissling RO (2006) Morbus Bechterew — neue Therapien, offene Fragen. Schweiz Med Forum 6: 163–171

    Google Scholar 

  40. Zochling J, van der Heijde D, Burgos-Vargas R et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65: 442–452

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. Antoni CE, Kavanaugh A, Kirkham B et al (2005) Sustained benefits of Infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis. Arthritis Rheum 52:1227–1236

    Article  CAS  PubMed  Google Scholar 

  2. Braun J, Sieper J (2006) Spondyloarthritiden. Z. Rheumatol 65: 613–632

    Article  CAS  PubMed  Google Scholar 

  3. Cauza E, Dunky A (2006) Psoriasis Arthritis. Wien Med Wochenschr 156: 587–595

    Article  PubMed  Google Scholar 

  4. Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57:1560–1563

    Article  PubMed  Google Scholar 

  5. Clegg DO, Reda DJ, Mejias E et al (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of veterans affairs cooperative study. Arthritis Rheum 39: 2013–2020

    Article  CAS  PubMed  Google Scholar 

  6. Feyertag J, Dunky A (2005) Arthritis psoriatica (Psoriasisarthritis). J Miner Stoffwechs 12: 105–109

    Google Scholar 

  7. Genth E (2008) Arthritis psoriatica und Arthritis bei gastrointestinalen Grundkrankheiten. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2.Auflage. Springer, Berlin Heidelberg New York, pp547–553

    Chapter  Google Scholar 

  8. Gladman DD, Helliwell P, Mease PJ et al (2004) Assessment of patients with psoriatic arthritis: A review of currently available measures. Arthritis Rheum 50: 24–35

    Article  PubMed  Google Scholar 

  9. Gladman DD, Antoni C, Mease P et al (2005) Psoriatic arthritis: Epidemiology, clinical features, course and outcome. Ann Rheum Dis 64 [Suppl II]: ii14–ii17

    Article  PubMed  Google Scholar 

  10. International Multi-centre Psoriasis and Psoriatic Arthritis Reliability Trial (GRAPPA-IMPART) (2007) Assessment of skin, joints, nails and dactylitis. To ronto, Canada

    Google Scholar 

  11. Lynch M, Ng CT, Saber TP, Grier A et al (2008) The 28 Joint count underestimates extent of disease in Psoriatic arthritis. Arthritis Rheum 58 [Suppl]: 363

    Google Scholar 

  12. Mease PJ, Goffe BS, Metz J et al (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356: 385–390

    Article  CAS  PubMed  Google Scholar 

  13. Märker-Hermann E, Behrens F (2009) Psoriasisarthritis Zielkriterien der Behandlung. Z Rheumatol. 68: 16–22

    Article  PubMed  Google Scholar 

  14. Moll JMH, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3: 51–78

    Article  Google Scholar 

  15. Nell Duxneuner P, Stamm T, Aletaha D et al (2007) Measures associated with disease activity in psoriatic arthritis. Arthritis Rheum 56 [Suppl]: 481

    Google Scholar 

  16. Österreichische Gesellschaft für Rheumatologie und Rehabilitation (2005) Österreichische Verschreibungsempfehlungen für TNF-Blocker bei Psoriasisarthritis. http://www.rheuma2000.at/

  17. Ritchlin CT, Kavanaugh A, Gladman D et al (2008) Treatment recommendation for psoriatic arthritis. Arthritis Rheum 58 [Suppl]: 363–364

    Google Scholar 

  18. Scheinecker C (2008) Pathogenese der Psoriasisarthritis. Fakten der Rheumatologie 2: 7–8

    Google Scholar 

  19. Smolen J (2008) Therapie der Psoriasisarthritis. Fakten Rheumatologie 2: 17–18

    Google Scholar 

  20. Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 54: 2665–2673

    Article  PubMed  Google Scholar 

  21. Amor B (1983) Reiter’s syndrome and reactive arthritis. Clin Rheumatol 2(4): 315–319

    Article  CAS  PubMed  Google Scholar 

  22. Bas S, Vischer TL (1998) Chlamydia trachomatis antibody detection and diagnosis of ractive arthritis. Br J Rheumatol 37: 1054–1059

    Article  CAS  PubMed  Google Scholar 

  23. Calin A (1984) Reiter’s Syndrome. In: Calin A (ed) Spondyloarthropathies. Grune & Stratton, Orlando, FL, pp 844–849

    Google Scholar 

  24. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34: 218–1227

    Article  Google Scholar 

  25. El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR Jr (1999) Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 42: 1696–1705

    Google Scholar 

  26. Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Groh A, Uksila J, Granfors K, Braun J, Sieper J (2001) Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 60: 337–343

    Article  CAS  PubMed  Google Scholar 

  27. Haibel H, Rudwaleit M, Sieper J, Zeidler H, Kuipers JG (2004) Diagnostik der reaktiven Arthritis. Z Rheumatol 63: 211–215

    CAS  PubMed  Google Scholar 

  28. Herzer P, Burmester GR, Genth E (2007) Diagnostische Kriterien Reaktive Arthritiden. In: Deutsche Gesellschaft für Rheumatologie e.V. Kommission für Qualitätssicherung (Hrsg) Qualitätssicherung in der Rheumatologie, 2. Auflage. Steinkopff

    Google Scholar 

  29. Kvien TK, Glennas A, Melby K, Granfors K, Andrup O, Karstensen B, Thoen JE (1994) Reactive arthritis: Incidence, triggering agents and clinical presentation. J Rheumatol 21: 115–122

    CAS  PubMed  Google Scholar 

  30. Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H (1991) Doubleblind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 34: 6–14

    Article  CAS  PubMed  Google Scholar 

  31. Maki-Ikola O, Leirisalo-Repo M, Kantele A, Toivanen P, Granfors K (1991) Salmonella-specific antibodies in reactive arthritis. J Infect Dis 164: 1141–1148

    CAS  PubMed  Google Scholar 

  32. Rabenau H, Berger A, Doerr HW, Weber B (1997) Testing for Chlamydia trachomatis in urine. Lancet 349: 1024–1025

    Article  CAS  PubMed  Google Scholar 

  33. Schnarr S, Jendro M.C. Wollenhaupt J, Zeidler H (2008) Reaktive Arthritiden. In: Zeidler H, Zache J, Hiepe F (Hrgs) Interdisziplinäre klinische Rheumatologie, 2. Auflage. Springer, Berlin Heidelberg New York, pp461–480

    Chapter  Google Scholar 

  34. Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S, Sorensen H, Distler A, Kingsley G (1992) Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol 19: 1236–1242

    CAS  PubMed  Google Scholar 

  35. Sieper J (2003) Reaktive Arthritis: Praktisches Vorgehen bei Diagnostik und Problematik der antibiotischen Therapie. Z Rheumatol 62: 110–111

    Article  CAS  PubMed  Google Scholar 

  36. Sieper J, Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Hiepe F, Alten R, Keitel W, Groh A, Uksila J, Eggens U, Granfors K, Braun J (1999) No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebocontrolled study. Arthritis Rheum 42: 1386–1396

    Article  CAS  PubMed  Google Scholar 

  37. Sieper J, Kingsley GH, Marker-Hermann E (1996) Aetiological agents and immune mechanisms in enterogenic reactive arthritis. Baillieres Clin Rheumatol 10: 105 121

    Article  PubMed  Google Scholar 

  38. Sieper J, Rudwaleit M, Braun J, van der Heijde D (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46: 319–327

    Article  PubMed  Google Scholar 

  39. Willkens RF (1981) Reiter’s syndrome. In: Arnett FC, Bitter T, Calin A, Fisher L, Ford DK, Good AE, Masi AT (eds) Evaluation of preliminary criteria for definite disease. Arthritis Rheum 24: 844–849

    Google Scholar 

Literatur

  1. Dallek R (2003) John F. Kennedy. Ein unvollendetes Leben. DVA, München

    Google Scholar 

  2. Dougados M, Van der Linden S, Juhlin R et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of Spondylarthropathy. Arthritis Rheum 34: 1218–1227

    Article  CAS  PubMed  Google Scholar 

  3. Genth E (2008) Arthritiden bei gastrointestinalen Erkrankungen. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Auflage. Springer, Berlin Heidelberg New York, pp554–559

    Google Scholar 

  4. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA (2007) Clin Gastroenterol Hepatol 5: 1424–1429

    Article  PubMed  Google Scholar 

  5. Miehle W, Fehr K, Schattenkirchner M, Tillmann K (2000) Arthritis bei Zöliakie. In: Rheumatologie in Praxis und Klinik, 2. Auflage. Thieme, Stuttgart, p709

    Google Scholar 

  6. Orchard TR, Wordsworth BP, Jwell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42: 387–391

    Article  CAS  PubMed  Google Scholar 

  7. Puchner R (1999) Enteropathische Arthritiden. Arzt Praxis 53: 676–681

    Google Scholar 

  8. Puchner R (2008) J. F. Kennedy. In: Loisl D, Puchner R (Hrsg) Diagnose Rheuma, 2. Auflage. Springer, Wien New York, p136

    Google Scholar 

  9. Mau W, Zeidler H (2008) Sonstige entzündliche Spondylopathien. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Auflage. Springer, Berlin Heidelberg New York, pp923–928

    Google Scholar 

  10. Mielants H, Veys EM, Cuvelier C et al (1995) The evolution of spondylarthropathies in relation to gut history: II. Histological aspects. J Rheumatol 22: 2273–2278

    CAS  PubMed  Google Scholar 

  11. Ronneberger M (2009) Enteropathische Arthritis. Z Rheumatol 68: 329–336

    Article  CAS  PubMed  Google Scholar 

  12. Stein J (2004) Gastrointestinale Komplikationen. In: Falkenbach A (Hrsg) Morbus Bechterew, pp211–245

    Google Scholar 

  13. Zochling J, Brandt J, Braun J (2005) The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology 44: 1483–1491

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internistischer Rheumatologe, Wels, Österreich

    Dr. Rudolf Puchner

Authors
  1. Dr. Rudolf Puchner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Puchner, R. (2010). Spondyloarthritiden. In: Rheumatologie aus der Praxis. Springer, Vienna. https://doi.org/10.1007/978-3-211-99713-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-99713-0_4

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-99712-3

  • Online ISBN: 978-3-211-99713-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation